1. Home
  2. IMNM vs COCO Comparison

IMNM vs COCO Comparison

Compare IMNM & COCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$22.03

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$76.96

Market Cap

3.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
COCO
Founded
2006
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
IMNM
COCO
Price
$22.03
$76.96
Analyst Decision
Strong Buy
Buy
Analyst Count
10
9
Target Price
$32.80
$57.75
AVG Volume (30 Days)
915.1K
1.6M
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
51.40
26.60
EPS
N/A
0.50
Revenue
$6,941,000.00
N/A
Revenue This Year
N/A
$16.12
Revenue Next Year
$1,127.34
$11.40
P/E Ratio
N/A
$151.99
Revenue Growth
N/A
N/A
52 Week Low
$7.96
$31.82
52 Week High
$27.65
$79.99

Technical Indicators

Market Signals
Indicator
IMNM
COCO
Relative Strength Index (RSI) 48.94 68.77
Support Level $19.23 $50.99
Resistance Level $23.24 $79.99
Average True Range (ATR) 1.27 2.73
MACD -0.05 -0.09
Stochastic Oscillator 55.07 76.77

Price Performance

Historical Comparison
IMNM
COCO

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

Share on Social Networks: